Skip to content

Capricor Therapeutics CAPR Change in Other Assets

Change in Other Assets at other companies

Pfizer logo
PfizerPFE
-$322.25M+61.9%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$14.55M-3.5%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$6.28M-239%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$28K
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Market cap$1.71B+303%
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's change in other assets?
Capricor Therapeutics (CAPR) reported change in other assets of -$979.78K in Q1 2026.
How has Capricor Therapeutics's change in other assets changed year-over-year?
Capricor Therapeutics's change in other assets decreased by 1666.2% year-over-year, from -$55.47K to -$979.78K.
What is the long-term trend for Capricor Therapeutics's change in other assets?
Over 3 years (2021 to 2025), Capricor Therapeutics's change in other assets has grown at a 201.9% compound annual growth rate (CAGR), from $148.73K to $4.09M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.